Market Overview

UPDATE: Jefferies Raises PT on Aetna Following Coventry Acquisition

Share:
Related AET
Citi Concerned With Near-Term Risks For Cotiviti, Initiates At Neutral
New Cancer Screening Recommendation Good For Exact Sciences: Canaccord
California insurance chief says Aetna-Humana merger "anti-competitive" (Seeking Alpha)

In a report published Thursday, Jefferies analyst David Windley reiterated a Buy rating on Aetna (NYSE: AET), and raised the price target from $69.00 to $74.00.

In the report, Jefferies noted, “We are raising our EPS projections to reflect the Coventry acquisition by 5-10c more than accretion guidance of $0.45-0.90 in 2014-15. The company's diversified business, strong execution, modest exposure to Exchange risk, and low-to-mid teens EPS growth make AET our favorite MCO. At 9.5x 2014E EPS, AET is second cheapest in the group with the most attractive risk/reward profile. Raising our PT to $74.”

Aetna closed on Wednesday at $60.29.

Latest Ratings for AET

DateFirmActionFromTo
Jun 2016BernsteinInitiates Coverage onOutperform
Apr 2016ClevelandInitiates Coverage onNeutral
Feb 2016BMO CapitalMaintainsOutperform

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: David Windley JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (AET)

View Comments and Join the Discussion!